Hydrolysis of steviol glycosides by beta-glucosidase

US11414689B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11414689-B2
Application numberUS-201916725242-A
CountryUS
Kind codeB2
Filing dateDec 23, 2019
Priority dateJun 30, 2017
Publication dateAug 16, 2022
Grant dateAug 16, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to the use of beta-glucosidase to enhance the production efficiency of desired steviol glycosides, such as rebaudioside M (reb M).

First claim

Opening claim text (preview).

What is claimed is: 1. A method of altering the glycosylation of a steviol glycoside, said method comprising: (a) exposing a first steviol glycoside to a Pichia sp. beta-glucosidase for sufficient time to generate a second steviol glycoside through the removal of at least one glucosyl group at the C19 position from said first steviol glycoside; and (b) collecting said second steviol glycoside. 2. The method of claim 1 , wherein said first steviol glycoside is rubusoside and a glucosyl group is removed from the C19 position of said rubusoside to produce steviol-13-glucoside. 3. The method of claim 1 , wherein said first steviol glycoside is stevioside and a glucosyl group is removed from the C19 position of said stevioside to produce steviolbioside. 4. The method of claim 1 , wherein said first steviol glycoside is Reb E and a glucosyl group is removed from the C19 position of said Reb E to produce stevioside. 5. The method of claim 1 , wherein said first steviol glycoside is Reb I and a glucosyl group is removed from the C19 position of said Reb I to produce Reb A. 6. The method of claim 1 , wherein said first steviol glycoside is Reb A and a glucosyl group is removed from the C19 position of said Reb A to produce Reb B. 7. The method of claim 5 , wherein further a glucosyl group is removed from the C19 position of said Reb A to produce Reb B. 8. The method of claim 1 , wherein said first steviol glycoside is Reb D and two glucosyl groups are removed from the C19 position of said Reb D to produce Reb B. 9. The method of claim 1 , wherein said first steviol glycoside is Reb G and a glucosyl group at the C19 position and a glucosyl group at the C13 position are removed from said Reb G to produce steviol-13-glucoside. 10. The method of claim 9 , wherein further a glucosyl group is removed from the C13 position of said steviol-13-glucoside to produce steviol. 11. The method of claim 1 , wherein said second steviol glycoside is Reb B. 12. The method of claim 1 , wherein said first steviol glycoside Reb A. 13. The method of claim 1 , further comprising the use of beta-galactosidase or pectinase enzymes to increase the speed of enzymatic hydrolysis. 14. The method of claim 1 , wherein the beta-glucosidase has an amino acid sequence that has at least 90% identity to SEQ ID NO:1. 15. The method of claim 1 , wherein the beta-glucosidase has an amino acid sequence that is at least 95% identical to SEQ ID NO:3. 16. The method of claim 1 , wherein exposing said first steviol glycoside to the beta-glucosidase comprises exposing said first steviol glycoside to disrupted Pichia cells thereby releasing said Pichia sp. beta-glucosidase from the Pichia cells. 17. The method of claim 2 , wherein further a glucosyl group is removed from the C13 position of said steviol-13-glucoside to produce steviol. 18. The method of claim 4 , wherein further a glucosyl group is removed from the C19 position of said stevioside to produce steviolbioside.

Assignees

Inventors

Classifications

  • produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

  • C12P19/56Primary

    having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin · CPC title

  • Artificial sweetening agents · CPC title

  • Polyterpene radicals · CPC title

  • Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11414689B2 cover?
The present disclosure relates to the use of beta-glucosidase to enhance the production efficiency of desired steviol glycosides, such as rebaudioside M (reb M).
Who is the assignee on this patent?
Conagen Inc
What technology area does this patent fall under?
Primary CPC classification C12P19/56. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).